Tingting Tan Xiaotong Lin Jing Ling Rong Wang Yue Chen Longmei Cai Jingyuan Sun Dehua Wu Guozhu Xie
10.3389/fimmu.2023.1115691
Front Immunol
2023 Jan 20;14:1115691.
pd-1 lenvatinib pembrolizumab primary resistance renal cell carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36742302/
Carcinoma, Renal Cell / pathology Kidney Neoplasms / drug therapy Kidney Neoplasms / pathology
Carcinoma, Renal Cell / pathology Kidney Neoplasms / drug therapy Kidney Neoplasms / pathology Case Reports Humans Phenylurea Compounds Prospective Studies lenvatinib Phenylurea Compounds
PMC9895929
36742302
Case report: Abolishing primary resistance to PD-1 blockade by short-term treatment of lenvatinib in a patient with advanced metastatic renal cell carcinoma
2023